Pathophysiology and therapeutic management of anemia in gastrointestinal disorders.
Autoimmune gastritis
Crohn’s disease
celiac disease
gastrointestinal bleeding
iron
ulcerative colitis
Journal
Expert review of gastroenterology & hepatology
ISSN: 1747-4132
Titre abrégé: Expert Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101278199
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
pubmed:
14
6
2022
medline:
22
7
2022
entrez:
13
6
2022
Statut:
ppublish
Résumé
Anemia is a common complication of gastrointestinal (GI) disorders, with a prevalence up to 60% in celiac disease (CeD) and inflammatory bowel disease (IBD). Iron deficiency anemia (IDA) is the most prevalent form of anemia in these conditions, but chronic inflammation and vitamin B12 deficiency represent other common contributing mechanisms, especially in IBD. We discuss the pathogenesis of anemia in various medical GI disorders, the sometime problematic distinction between IDA, anemia of inflammation (AI) and the association of the two, and therapeutic and preventive measures that can be useful for the management of anemia in GI disorders. Unfortunately, with the exception of IDA and AI in IBD, large RCT concerning the treatment of anemia in GI disorders are lacking. Anemia management strategies in GI disorders are outlined, with a focus on the main prevention, diagnostic, and therapeutic measures. Specific problems and situations such as the role of gluten-free diet for IDA treatment in CeD, the choice between oral and parenteral supplementation of iron or vitamin B12 in carential anemias, the use of endoscopic procedures to stop bleeding in intestinal angiodysplasia and preventive/treatment strategies for NSAID-associated GI bleeding are discussed.
Identifiants
pubmed: 35696485
doi: 10.1080/17474124.2022.2089114
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM